medigraphic.com
ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana

2009, Number 2

<< Back

Rev ADM 2009; 66 (2)

Leukocyte Esterase and Interleukin 1 beta in gingival crevicular fluid as mark predictors in periodontal disease

Ávila AD, Martínez SE, López SS, Armenta SA, Mejía ZR, Cruz LA

Language: Spanish
References: 52
Page: 48-59
PDF size: 460.85 Kb.


ABSTRACT

Purpose. To value the utility of the leukocyte esterase (LE) and Interleukin 1 beta (1L-1$) as mark predictors of progresión of peridontal disease. Material and methods. A case control study was made between august 2005 and february 2006 in endoperiodonthology clinic in Tlalnepantla, Estado de México. Cases were patients with confirmed periodontal disease diagnosis. Samples from 290 patients were colected with paper points in the gingival sulcus. Levels of LE and IL-1$ in gingival crevicular fluid (GCF) was measured. The semiquantification of LE was measured with reactive strips and quantification with spectrofotomether at 400 nm calculating an absorbent factor expressed in leukocytes/:L. The IL-1$ was quantified with an ELISA test. Asociated risk factors were evaluated, deep probing, bone resorption and plax index obtained from the clinic file. Odds Ratio were estimated. Results. The semiquantification LE was positive in cases and the quantification showed from 11 to 80 leukocytes/: L for cases and from 0 to 10 in controls. The IL-1$ in cases reported levels upr to 5.2 ng/ml. The enzymatic tests had positive asociation with deep probing up to 6 mm and bone resorption up to 4 mm. and plax index higher than 70%. Conclusions. The progresión of periodontal disease can be estimated by the levels of LE and IL-1$ founded in GCF.


REFERENCES

  1. 1 . Ozmeric N . Advances in periodontal markers Clin Chim Ac ta 2004;343(1-2):1-16.

  2. Armitage GC . Periodontal diseases : Diagnosis. Ann Periodontol 1996;1 (1):37215.

  3. Haffajee AD, Socransky SS, Goodson JM. Periodontal disease activity. J Periodontol Res 1996;175:521-2.

  4. McCauley LK, Nohutcu RM. Mediators of periodontal osseous destruction and remodeling: Principies and implications for diagnosis and therapy. J Periodontol 2002;72:1377-91.

  5. Scannapieco FA. Periodontal inflammation: From gingivitis to systemic disease. Compend Contin Educ Dent 2004 Ju1;25(7 Suppl 1):16’25.

  6. Champagne CM, Buchanan W, Reddy MS, Preiser JS, Beck JD, Of fenbacher S . Potential for gingival crevice fluid markers as predictors of risk for periodontal diseases. Periodontology 2000 2003;31(1):167-80.

  7. Gilham D, Lehner R. Techniques to measure lipase and esterase activity in vitro. Methods 2005 Jun;36(2):139-47.

  8. Rover S, Cesura AM, Huguenin P, Kettler R,Szente A. Synthesis and bochemical evaluation of N-(4-phenilthiazol-2-yl)benzenesulfonamides as high af finit y inhibito rs of k ynurenin e 3 - hidrox ylase. J Me d Chem19 97 Dec;40(26):4378-85.

  9. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003 Mar;74 (3);391401.

  10. Takashiba S, Naruishi K, Murayama Y. Perspective of cytokine regulation for periodontal treatment: Fibroblast biology. J Periodontol 2003;74;103-10.

  11. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: Summary of developments, clinical implications and future directions. Periodontolgy 2000 1997 Jun;14:216-48.

  12. D einzer R , Waschul B , H er for th A . Effec ts of exp erimental gingivitis on crevicular PGE2 in a split mouth trial. J Clin Periodontol 2004;31(7);501-5.

  13. Pirog K, Stabinsky Y,Goldmna R. Catálogo Peprotech. Cytokine Index .(2006),93.

  14. Research, Science and Therapy Committee of the American Academy of Periodontology. Epidemiology of periodontal diseases. Position Paper. Academy Report. J Periodontol 2005;76:1406-19.

  15. Lindhe J. Periodontologia clinica e Implantologia odontológica Epidemiologia de la enfermedad periodontal Editorial Panamericana. (2003) 69-365.

  16. Herrera LF, llisástigui-Ortueta ZT, Zazueta-Hernández MA. Prevalencia, extensión y severidad de periodontitis de inicio temprano en jóvenes estudiantes. Disponible en: http://www.ucmh.sld.cu/rhab/articulorevl4/periodontitis.htm. [2007 abril 5].

  17. Secretaría De Salud. Sistema Nacional de Vigilancia Epidemiológica. Incidencia de los casos nuevos de enfermedades por grupo de edad. Boletín Epidemiología . 2006:23;1:35-37

  18. Bimstein E,Small PA Jr, Magnusson 1. Leukocyte esterase and protein levels in saliva, as indicators of gingival and periodontal diseases in children. Pediatr Dent.2004;26;310-315.

  19. Kaufman E, Lamster IB. Analysis of saliva for periodontal diagnosis. J Clin Periodontol 2000;27:453-65.

  20. Igman T, Sorsa T, Konttinen YT, Liede K, Saari H, Lindy O, et al. Salivary collagenase, elastase- and trypsin, like proteases as biochemical markers of periodontal tissue destruction in adult and localized juvenile periodontitis. Oral Microbiol Immuno12003;8:298-305.

  21. Nieminen A, Nordlund L, Uitto VJ. The effect of treatment on the activity of salivary proteases and glycosidasis in adults with advance periodontitis. J Periodontol 2003;64:297-301.

  22. Elgun S, Ozmeric N, Dermitas S, Alanine aminopeptidase and dipeptidylpeptidase IV in saliva: the possible role in periodontal disease. Clin Chim Acta 2000;298:187-191.

  23. Ozmeric N, Elgun S, Uraz A. Salivary arginase in patients with adult periodontitis. Clin Oral Investig 2000;4:21-4. 24. Gossrau R. Peptidases II. Localization of dipeptidylpeptidase IV (DPP IV). Histochemical and biochemical study. Histochemistry 1999;60:231-48.

  24. Lamster IB, Kaufman E, Grbic JT, Winston LJ, Singer RE. Betaglucuronidase activity in saliva: relationship to clinical periodontal parameters. J Periodontol 2003;74:353-9.

  25. Igman T, Tervahartiala T, Ding Y, Tschesche H, Haerian A, Kinane DF, et al. Matrix metalloproteinases and their inhibitirs in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 1996;23:1127-32.

  26. Van Steijn GJ, Amerogen AV, Veerman EC, Kasanmoentalib S, Overdijk B, Effect of periodontal treatment on the activity of chitinase in whole saliva of periodontitis patients. J Periodontal Res 2002;37:245-9.

  27. Cruz-Romero G, Mantilla J. Detección de Porphyromonas endodontalis en saliva total por PCR. Colombia Médica 2004;36: supl 1:39-47.

  28. Stashenko et al, Bone resortion and profile of body cytokines in periodontal disease. J Periodonto11994,1;62;504-509.

  29. Faizuddin M, Bharathi SH, Rohini N. Estimation of Interleukin-1(3 levels in the gingival crevicular fluid in health and in inflammatory periodontal disease.J Periodont Res. 2003;38;111-114.

  30. Nishihara T,Koseki T. Microbial etiology of periodontitis. Periodontology 2000 2004;36:14-26

  31. Delima A,Vand Dyke T. Origin and function of the cellular components in gingival crevice fluid. Periodontology 2000 2003;31:55-76.

  32. Groenink J, Walgreen Weterings E, Nazmi K, Bolscher JG, Veerman EC, van Winkelhoff AJ, et al. Salivary lactoferrin and low-Mr mucin MG2 in Actinobacillus actinomycetemcomitans-associated periodontitis. J Clin Periodontol 2001;26:269-275.

  33. Ebersole J. Humoral inmune responses in gingival crevice fluid: local and systemic implications. Periodontology 2000 2003; 31:135-166

  34. Engebretson SP,Hey-Hadavi J,Ehrhardt FJ, Hsu D, Celenti RS,Grbic JT,Lamster Gingival crevicular fluid levels of interleukin-1 beta and glycemic control in patients with chonic periodontitis and type 2 diabetes. J Periodonto1.2004 Sep;75(9):1203-1208.

  35. Eley B,Cox S. Proteolytic and hydrolitic enzymes from putative periodontal pathogens:characterization, molecular genetics,effects on host defenses and tissues and detection in gingival crevice fluid. Periodontology 2000 2003;31:105-124

  36. Velli-Jukka U. Gingival crevice fluid: an introducction. Periodontology 2000 2003; 31: 9-11.

  37. Page RC, Kornman KS. The Pathogenesis of human periodontitis: an introduction. 1997;14; 9-11.

  38. Havemouse-Poulsen A, Korsbaek-Sorensen L, Stoltzer K, Bendtzer K, Holmstrup P. Cytokine profiles in peripheral blood and whole blood cells associated with ggressive periodontitis, Juvenile Idiopathic Arthritis and Rheumatoid Arthritis J Periodonto12005; 76; 2276-2285.

  39. Alugupalli K , Kalfas S, Edwardsson S, Naidu A , Lactoferrin interaction with Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 2005;10:35-41.

  40. Guerrero F,Torres M. Identificación de factores de riesgo asociado a enfermedad periodontal y enfermedades sistémicas. ADM 2004 ;3:92-96

  41. López- Corre A . Asociación de enfermedad periodontal con enfermedades cardiovasculares. Colombia Médica 2004 ;36 : sup 12:17-22.

  42. Sukugawa F. Fac tores de riesgo para enfermedades gingivo periodontales. Colombia Médica 2004 ; 37 sup11 :25-31.

  43. Jin L, Yu C, Corbett EF. Granulocyte elastase activity in state and flow gingival crevicular fluid. J Periodontol Res;2003;38;303-310.

  44. Suomalainen K, Saxen L, Vilja P, Tenovuo J, Perixidases, lactoferrin and lysozyme in peripheral blood neutrophils, gingival crevicular fluid and whole saliva of patients with localized juvenile periodontitis. Oral Dis 2003;2:29-34.

  45. Arce RM. Terapia periodontal del futuro. Colombia Médica 2004;35: supl 1:40-47.

  46. Miyasaki KT, Nisengard RJ, Haake SK. Immunity and inflammation; basic concepts. In: MG Newman, HH Takei, FA Carranza, editors. Carranza’s Clinical Periodontology, 9th edition. W.B. Saunders 2001 Philadelphia. PA. P. 113-32.

  47. Engebretson SP, Grbic JT,Singer R, Lamster IB. GCF IL-1 beta profiles in periodontal disease. J Clin Periodontol. 2002 Jan;29(1):48-53.

  48. Delaleu N, Bickel M. Interleukin-1R and Interleukin 18;Regulation and activity in local inflammation. Periodontology 2000:2004;35;42-52.

  49. Konopka T,Rutkowska M, Hirnle L,Kopec W. IL-1beta and PGE2 production in whole blood and gingival fluid in women with periodontitis and preterm low birth weight. Ginekol Pol. 2004 May;75(5):352-60.

  50. Loos B. Systemic markers of inflammation in periodontitis. J Periodontal 2005; 76; 2106-2115

  51. Davis E. Scott A,Macckey & Howard T, Mac Donald T. Systemic disease and periodontitis manifestations of neutrophil dysfunction. Periodontology2000;2003;32;82-104.

  52. Sinem E,Sahingur & Cohen R. Analysis of host response and risk of disease progression.Periodontology 2000;2004;34;57-83.




2020     |     www.medigraphic.com